{"id":"W1972912578","doi":"10.1016/s1470-2045(13)70184-0","title":"Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Aflibercept; Docetaxel; Medicine; Prednisone; Prostate cancer; Placebo; Clinical endpoint; Internal medicine; Oncology; Chemotherapy; Surgery; Cancer; Bevacizumab; Urology; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002262348,0.002801897,0.005385211,0.0008093007,0.0007231168,0.001640551,0.001509065,0.003325045,0.01102718],"category_scores_gemma":[0.002205784,0.001277435,0.003845067,0.0007054812,0.002168837,0.001740818,0.0006348106,0.004536364,0.00179596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008698911,"about_ca_system_score_gemma":0.001175405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001827291,"about_ca_topic_score_gemma":0.003259204,"domain_scores_codex":[0.9990401,0.0004885334,0.00006504871,0.000201452,0.00005386883,0.0001510794],"domain_scores_gemma":[0.9988783,0.0003728852,0.000222497,0.0001004739,0.00005958229,0.0003662783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9921038,0.001529956,0.00008009902,0.0004963026,0.0005187585,0.00001593078,0.00002453,0.0001275802,0.0005145626,0.00004801812,0.0003071488,0.004233276],"study_design_scores_gemma":[0.9833272,0.0159127,0.0002035856,0.00001759981,0.0001802157,0.00001022558,0.000007323536,0.00008718144,0.00005309394,0.00004761184,0.0001469029,0.000006475324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9614772,0.01769912,0.00167256,0.001571288,0.002662308,0.008583874,0.002128731,0.0004472744,0.003757611],"genre_scores_gemma":[0.9755798,0.006722425,0.002051079,0.001455081,0.001207379,0.005761901,0.001176491,0.00005890816,0.005986817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01102718,"threshold_uncertainty_score":0.03688961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1222225973170984,"score_gpt":0.4218269267105545,"score_spread":0.2996043293934561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}